Blood transfusion services is an integral part of medical therapy that can be life-saving in critical cases and has a key role in solid organ and stem cell transplant programs. As with any treatment, however, transfusion of blood or blood components must be ordered and administered safely and judiciously under the guidance of a medical doctor. Transfusion is more than a single discrete event—it is a process that begins from donor vein to recipient vein. The transfusion chain begins with donor considerations (whether their donation is safe for them to do and whether the donation is safe for any patient to receive).
Once blood is collected, the safety of the blood product is a main focus of activity (transfusion-transmitted testing, compatibility testing, necessary modifications such as irradiation or leukocyte reduction).
The endpoint of the transfusion process involves recipient considerations (proper identification of the unit and the patient, appropriateness of blood as the best treatment modality, administration of the unit, evaluation of the recipient), and safe disposal of unused or empty blood bags as per BMW policy. With the mission of “To provide best-in-class safe, secure, cost-effective, hassle-free supply of blood products and perform a critical role in clinical services to meet the needs of the healthcare community, patients, and our donors through advanced transfusion medicine,” the Blood Center, Mahatma Gandhi Medical College & Hospital (MGMCH) is providing world-class transfusion services.
The Blood Center, MGMCH is the first NABH-accredited blood center and is ranked number one by the National Blood Transfusion Council among all medical college-based blood centers in the state of Rajasthan. It has the first state-of-the-art Transplant Immunology lab (NABL accredited) with facilities like Luminex, Flow Cytometer, Next-Generation Sequencing (NGS), and has received appreciation for ABOi renal transplants and cadaveric transplant HLA testing in the state of Rajasthan.
The Blood Center has most recent and advanced facilities including:
- Hematopoietic stem cell harvesting
- Granulocyte concentrate, lymphocyte collection
- Leukodepleted blood products, blood irradiation, single donor platelets
- NAT-tested blood products
- Component modification for intrauterine transfusion
- Thalassemia screening
- Immunophenotyping and molecular testing for leukemia
- Workup for autoimmune hemolytic anemia
- Red cell antibody screening of all donors and recipients
- Therapeutic procedures, i.e., therapeutic plasma exchange in life-threatening cases of Myasthenia Gravis, Guillain-Barré Syndrome, and double cascade plasmapheresis in ABO-incompatible renal transplants.
We are actively participating in the Haemovigilance Program of India (HvPI), Ministry of Health and Family Welfare, Government of India, with a dedicated haemovigilance nurse.
The Blood Center, MGMCH, is among 21 institutes in India that participated in the clinical trial of COVID-19 Convalescent Plasma (CCP) therapy, the “PLACID trial” conducted by ICMR during the pandemic. This is the largest trial on CCP across the world, and we got the opportunity to serve patients by providing the maximum number of CCP units not only in Jaipur but also across the state.
We are proud to be the first NABH-accredited Blood Center in Rajasthan and achieved Association for the Advancement of Blood & Biotherapies(AABB) Quality Certificate first few in Asia. We established the first Transplant Immunology lab with Luminex and received an appreciation award for ABOi renal transplants in Rajasthan. First blood centre among medical college-based blood centre in Rajasthan, ranked by the National Blood Transfusion Council, Government of India. We offer all recent and advanced facilities, including stem cell harvesting, and we run a successful Haemovigilance Program with a dedicated haemovigilance nurse.